153 related articles for article (PubMed ID: 10641821)
1. Prevention of cardiovascular risk factors in the first place.
Labarthe DR
Prev Med; 1999 Dec; 29(6 Pt 2):S72-8. PubMed ID: 10641821
[TBL] [Abstract][Full Text] [Related]
2. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
3. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
[TBL] [Abstract][Full Text] [Related]
4. Issues for cardiovascular disease risk factor development in Europe.
De Backer GG; Maes L; Van de Mieroop E
Prev Med; 1999 Dec; 29(6 Pt 2):S96-101. PubMed ID: 10641825
[TBL] [Abstract][Full Text] [Related]
5. Primordial prevention of cardiovascular disease through applied genetics.
Williams RR; Hopkins PN; Stephenson S; Wu L; Hunt SC
Prev Med; 1999 Dec; 29(6 Pt 2):S41-9. PubMed ID: 10641817
[TBL] [Abstract][Full Text] [Related]
6. A heart-healthy and "stroke-free" world through policy development, systems change, and environmental supports: a 2020 vision for sub-Saharan Africa.
Mensah GA
Ethn Dis; 2003; 13(2 Suppl 2):S4-12. PubMed ID: 13677406
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cardiovascular disease--opportunities for progress.
Oberman A; Kuller LH; Carleton RA
Prev Med; 1994 Sep; 23(5):727-32. PubMed ID: 7845948
[TBL] [Abstract][Full Text] [Related]
8. Socioeconomic considerations in the primordial prevention of cardiovascular disease.
Kaplan GA; Lynch JW
Prev Med; 1999 Dec; 29(6 Pt 2):S30-5. PubMed ID: 10641815
[TBL] [Abstract][Full Text] [Related]
9. Physical activity and cardiovascular disease risk factors in children and adolescents: an overview.
Eisenmann JC
Can J Cardiol; 2004 Mar; 20(3):295-301. PubMed ID: 15054507
[TBL] [Abstract][Full Text] [Related]
10. [Primary prevention of cardiovascular disease].
Katić T; Sakić I; Bergovec M
Acta Med Croatica; 2009 Feb; 63(1):71-4. PubMed ID: 19681467
[TBL] [Abstract][Full Text] [Related]
11. Primary prevention of cardiovascular disease risk factors: review and implications for population-based practice.
Meininger JC
Adv Pract Nurs Q; 1997; 3(2):70-9. PubMed ID: 9432456
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease.
Emberson J; Whincup P; Morris R; Walker M; Ebrahim S
Eur Heart J; 2004 Mar; 25(6):484-91. PubMed ID: 15039128
[TBL] [Abstract][Full Text] [Related]
13. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
[TBL] [Abstract][Full Text] [Related]
14. Effect of 5-year community intervention Hartslag Limburg on cardiovascular risk factors.
Schuit AJ; Wendel-Vos GC; Verschuren WM; Ronckers ET; Ament A; Van Assema P; Van Ree J; Ruland EC
Am J Prev Med; 2006 Mar; 30(3):237-42. PubMed ID: 16476640
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India.
Chow CK; Joshi R; Gottumukkala AK; Raju K; Raju R; Reddy S; Macmahon S; Neal B
Am Heart J; 2009 Sep; 158(3):349-55. PubMed ID: 19699856
[TBL] [Abstract][Full Text] [Related]
16. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
17. Childhood IQ and cardiovascular disease in adulthood: prospective observational study linking the Scottish Mental Survey 1932 and the Midspan studies.
Hart CL; Taylor MD; Smith GD; Whalley LJ; Starr JM; Hole DJ; Wilson V; Deary IJ
Soc Sci Med; 2004 Nov; 59(10):2131-8. PubMed ID: 15351478
[TBL] [Abstract][Full Text] [Related]
18. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
19. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
20. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
